- Home
- SLNO vs INTA Comparison
SLNO vs INTA Comparison
Compare SLNO & INTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SLNO | INTA |
|---|---|---|
| Founded | 1999 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.2B |
| IPO Year | 2014 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SLNO | INTA |
|---|---|---|
| Price | $52.86 | $23.45 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 7 |
| Target Price | ★ $83.00 | $41.43 |
| AVG Volume (30 Days) | ★ 6.1M | 703.6K |
| Earning Date | 05-08-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 108.90 | 48.89 |
| EPS | ★ 0.39 | N/A |
| Revenue | $1,450,788.00 | ★ $504,120,000.00 |
| Revenue This Year | $150.46 | $15.91 |
| Revenue Next Year | $50.37 | $13.78 |
| P/E Ratio | $135.49 | ★ N/A |
| Revenue Growth | ★ 138.82 | 17.09 |
| 52 Week Low | $29.43 | $19.24 |
| 52 Week High | $89.12 | $58.79 |
Technical Indicators
Market Signals| Indicator | SLNO | INTA |
|---|---|---|
| Relative Strength Index (RSI) | 77.04 | 50.88 |
| Support Level | $48.91 | $23.23 |
| Resistance Level | $55.47 | $24.15 |
| Average True Range (ATR) | 0.11 | 1.21 |
| MACD | -0.45 | 0.21 |
| Stochastic Oscillator | 92.86 | 76.42 |
Price Performance
Historical ComparisonAbout SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.
About INTA Intapp Inc.
Intapp Inc is a provider of industry-specific, cloud-based software solutions for the professional and financial services industry. It empowers private capital,g, legal, accounting, and consulting firms with the technology needed to meet rapidly changing client, investor, and regulatory requirements. Geographically, it derives a majority of its revenue from the United States and also has a presence in the United Kingdom and the Rest of the world.